Effect of FR167653, a cytokine suppressive agent, on endotoxin-induced disseminated intravascular coagulation
- 24 October 1996
- journal article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 314 (1-2), 137-142
- https://doi.org/10.1016/s0014-2999(96)00537-7
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Increased plasma level of interleukin-6 in disseminated intravascular coagulationBlood Coagulation & Fibrinolysis, 1993
- Comparison of Peripheral Blood Leukocyte Kinetics After Live Escherichia coli, Endotoxin, or Interleukin-1 α Administration Studies Using a Novel Interleukin-1 Receptor AntagonistAnnals of Surgery, 1993
- Protein C and S deficiency in severe infectious purpura of children: A collaborative study of 40 casesIntensive Care Medicine, 1992
- Plasma level of tumor necrosis factor in disseminated intravascular coagulationAmerican Journal of Hematology, 1991
- The Proinflammatory Cytokines Interleukin-l and Tumor Necrosis Factor and Treatment of the Septic Shock SyndromeThe Journal of Infectious Diseases, 1991
- Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.JCI Insight, 1988
- Modulation of endothelial cell hemostatic properties by tumor necrosis factor.The Journal of Experimental Medicine, 1986
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985
- Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells.The Journal of Experimental Medicine, 1984
- Cultured human endothelial cells generate tissue factor in response to endotoxin.JCI Insight, 1983